164 related articles for article (PubMed ID: 33208383)
1. Combining evidence for and against pathogenicity for variants in cancer susceptibility genes: CanVIG-UK consensus recommendations.
Garrett A; Durkie M; Callaway A; Burghel GJ; Robinson R; Drummond J; Torr B; Cubuk C; Berry IR; Wallace AJ; Ellard S; Eccles DM; Tischkowitz M; Hanson H; Turnbull C;
J Med Genet; 2021 May; 58(5):297-304. PubMed ID: 33208383
[TBL] [Abstract][Full Text] [Related]
2. Cancer Variant Interpretation Group UK (CanVIG-UK): an exemplar national subspecialty multidisciplinary network.
Garrett A; Callaway A; Durkie M; Cubuk C; Alikian M; Burghel GJ; Robinson R; Izatt L; Talukdar S; Side L; Cranston T; Palmer-Smith S; Baralle D; Berry IR; Drummond J; Wallace AJ; Norbury G; Eccles DM; Ellard S; Lalloo F; Evans DG; Woodward E; Tischkowitz M; Hanson H; Turnbull C;
J Med Genet; 2020 Dec; 57(12):829-834. PubMed ID: 32170000
[TBL] [Abstract][Full Text] [Related]
3. Reclassification of clinically-detected sequence variants: Framework for genetic clinicians and clinical scientists by CanVIG-UK (Cancer Variant Interpretation Group UK).
Loong L; Garrett A; Allen S; Choi S; Durkie M; Callaway A; Drummond J; Burghel GJ; Robinson R; Torr B; Berry IR; Wallace AJ; Eccles DM; Ellard S; Baple E; Evans DG; Woodward ER; Kulkarni A; Lalloo F; Tischkowitz M; Lucassen A; Hanson H; Turnbull C;
Genet Med; 2022 Sep; 24(9):1867-1877. PubMed ID: 35657381
[TBL] [Abstract][Full Text] [Related]
4. vaRHC: an R package for semi-automation of variant classification in hereditary cancer genes according to ACMG/AMP and gene-specific ClinGen guidelines.
Munté E; Feliubadaló L; Pineda M; Tornero E; Gonzalez M; Moreno-Cabrera JM; Roca C; Bales Rubio J; Arnaldo L; Capellá G; Mosquera JL; Lázaro C
Bioinformatics; 2023 Mar; 39(3):. PubMed ID: 36916756
[TBL] [Abstract][Full Text] [Related]
5. Variant Classification Concordance using the ACMG-AMP Variant Interpretation Guidelines across Nine Genomic Implementation Research Studies.
Amendola LM; Muenzen K; Biesecker LG; Bowling KM; Cooper GM; Dorschner MO; Driscoll C; Foreman AKM; Golden-Grant K; Greally JM; Hindorff L; Kanavy D; Jobanputra V; Johnston JJ; Kenny EE; McNulty S; Murali P; Ou J; Powell BC; Rehm HL; Rolf B; Roman TS; Van Ziffle J; Guha S; Abhyankar A; Crosslin D; Venner E; Yuan B; Zouk H; ; Jarvik GP
Am J Hum Genet; 2020 Nov; 107(5):932-941. PubMed ID: 33108757
[TBL] [Abstract][Full Text] [Related]
6. Determination of Pathogenicity of
Brown A; Zamanpoor M; Love DR; Prosser DO
Sultan Qaboos Univ Med J; 2019 Nov; 19(4):e324-e334. PubMed ID: 31897316
[TBL] [Abstract][Full Text] [Related]
7. Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium.
Amendola LM; Jarvik GP; Leo MC; McLaughlin HM; Akkari Y; Amaral MD; Berg JS; Biswas S; Bowling KM; Conlin LK; Cooper GM; Dorschner MO; Dulik MC; Ghazani AA; Ghosh R; Green RC; Hart R; Horton C; Johnston JJ; Lebo MS; Milosavljevic A; Ou J; Pak CM; Patel RY; Punj S; Richards CS; Salama J; Strande NT; Yang Y; Plon SE; Biesecker LG; Rehm HL
Am J Hum Genet; 2016 Jun; 98(6):1067-1076. PubMed ID: 27181684
[TBL] [Abstract][Full Text] [Related]
8. Expanding ACMG variant classification guidelines into a general framework.
Masson E; Zou WB; Génin E; Cooper DN; Le Gac G; Fichou Y; Pu N; Rebours V; Férec C; Liao Z; Chen JM
Hum Genomics; 2022 Aug; 16(1):31. PubMed ID: 35974416
[TBL] [Abstract][Full Text] [Related]
9. [A Chinese interpretation for the "ACGS Best Practice Guidelines for Variant Classification in Rare Disease 2020"].
Chen D
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Aug; 40(8):915-921. PubMed ID: 37532488
[TBL] [Abstract][Full Text] [Related]
10. Adapting the ACMG/AMP variant classification framework: A perspective from the ClinGen Hemoglobinopathy Variant Curation Expert Panel.
Kountouris P; Stephanou C; Lederer CW; Traeger-Synodinos J; Bento C; Harteveld CL; Fylaktou E; Koopmann TT; Halim-Fikri H; Michailidou K; Nfonsam LE; Waye JS; Zilfalil BA; Kleanthous M;
Hum Mutat; 2022 Aug; 43(8):1089-1096. PubMed ID: 34510646
[TBL] [Abstract][Full Text] [Related]
11. A Collaborative Effort to Define Classification Criteria for ATM Variants in Hereditary Cancer Patients.
Feliubadaló L; Moles-Fernández A; Santamariña-Pena M; Sánchez AT; López-Novo A; Porras LM; Blanco A; Capellá G; de la Hoya M; Molina IJ; Osorio A; Pineda M; Rueda D; de la Cruz X; Diez O; Ruiz-Ponte C; Gutiérrez-Enríquez S; Vega A; Lázaro C
Clin Chem; 2021 Mar; 67(3):518-533. PubMed ID: 33280026
[TBL] [Abstract][Full Text] [Related]
12. Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC).
Horak P; Griffith M; Danos AM; Pitel BA; Madhavan S; Liu X; Chow C; Williams H; Carmody L; Barrow-Laing L; Rieke D; Kreutzfeldt S; Stenzinger A; Tamborero D; Benary M; Rajagopal PS; Ida CM; Lesmana H; Satgunaseelan L; Merker JD; Tolstorukov MY; Campregher PV; Warner JL; Rao S; Natesan M; Shen H; Venstrom J; Roy S; Tao K; Kanagal-Shamanna R; Xu X; Ritter DI; Pagel K; Krysiak K; Dubuc A; Akkari YM; Li XS; Lee J; King I; Raca G; Wagner AH; Li MM; Plon SE; Kulkarni S; Griffith OL; Chakravarty D; Sonkin D
Genet Med; 2022 May; 24(5):986-998. PubMed ID: 35101336
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of functional assay evidence use by ClinGen Variant Curation Expert Panels.
Kanavy DM; McNulty SM; Jairath MK; Brnich SE; Bizon C; Powell BC; Berg JS
Genome Med; 2019 Nov; 11(1):77. PubMed ID: 31783775
[TBL] [Abstract][Full Text] [Related]
14. Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteria.
Pejaver V; Byrne AB; Feng BJ; Pagel KA; Mooney SD; Karchin R; O'Donnell-Luria A; Harrison SM; Tavtigian SV; Greenblatt MS; Biesecker LG; Radivojac P; Brenner SE;
Am J Hum Genet; 2022 Dec; 109(12):2163-2177. PubMed ID: 36413997
[TBL] [Abstract][Full Text] [Related]
15. ClinGen Pathogenicity Calculator: a configurable system for assessing pathogenicity of genetic variants.
Patel RY; Shah N; Jackson AR; Ghosh R; Pawliczek P; Paithankar S; Baker A; Riehle K; Chen H; Milosavljevic S; Bizon C; Rynearson S; Nelson T; Jarvik GP; Rehm HL; Harrison SM; Azzariti D; Powell B; Babb L; Plon SE; Milosavljevic A;
Genome Med; 2017 Jan; 9(1):3. PubMed ID: 28081714
[TBL] [Abstract][Full Text] [Related]
16. Variant Interpretation for Dilated Cardiomyopathy: Refinement of the American College of Medical Genetics and Genomics/ClinGen Guidelines for the DCM Precision Medicine Study.
Morales A; Kinnamon DD; Jordan E; Platt J; Vatta M; Dorschner MO; Starkey CA; Mead JO; Ai T; Burke W; Gastier-Foster J; Jarvik GP; Rehm HL; Nickerson DA; Hershberger RE; ;
Circ Genom Precis Med; 2020 Apr; 13(2):e002480. PubMed ID: 32160020
[TBL] [Abstract][Full Text] [Related]
17. Differences in patient ascertainment affect the use of gene-specified ACMG/AMP phenotype-related variant classification criteria: Evidence for TP53.
Fortuno C; Pesaran T; Dolinsky J; Yussuf A; McGoldrick K; Goldgar D; James PA; Spurdle AB
Hum Mutat; 2020 Mar; 41(3):537-542. PubMed ID: 31898864
[TBL] [Abstract][Full Text] [Related]
18. Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results.
Plon SE; Eccles DM; Easton D; Foulkes WD; Genuardi M; Greenblatt MS; Hogervorst FB; Hoogerbrugge N; Spurdle AB; Tavtigian SV;
Hum Mutat; 2008 Nov; 29(11):1282-91. PubMed ID: 18951446
[TBL] [Abstract][Full Text] [Related]
19. Recommendations for laboratory workflow that better support centralised amalgamation of genomic variant data: findings from CanVIG-UK national molecular laboratory survey.
Allen S; Loong L; Garrett A; Torr B; Durkie M; Drummond J; Callaway A; Robinson R; Burghel GJ; Hanson H; Field J; McDevitt T; McVeigh TP; Bedenham T; Bowles C; Bradshaw K; Brooks C; Butler S; Del Rey Jimenez JC; Hawkes L; Stinton V; MacMahon S; Owens M; Palmer-Smith S; Smith K; Tellez J; Valganon-Petrizan M; Waskiewicz E; Yau M; Eccles DM; Tischkowitz M; Goel S; McRonald F; Antoniou AC; Morris E; Hardy S; Turnbull C
J Med Genet; 2024 Mar; 61(4):305-312. PubMed ID: 38154813
[TBL] [Abstract][Full Text] [Related]
20. Good performance of the criteria of American College of Medical Genetics and Genomics/Association for Molecular Pathology in prediction of pathogenicity of genetic variants causing thoracic aortic aneurysms and dissections.
Ponińska JK; Bilińska ZT; Truszkowska G; Michalak E; Podgórska A; Stępień-Wojno M; Chmielewski P; Lutyńska A; Płoski R
J Transl Med; 2022 Jan; 20(1):42. PubMed ID: 35078481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
